Chase Sapphire Reserve fee increases to $795 amid benefits overhaul
That annual fee is currently higher than just about every other premium credit card, including The Platinum Card® from American Express (which is also getting its own card refresh). It's also much higher than the Chase Sapphire Preferred® Card.
In addition, Chase will be launching its first Sapphire-related business card (also on June 23, 2025), the Chase Sapphire Reserve for Business.
Annual fee: Raised to $795 (from $550)
Authorized user fee: $195 (from $75)
Rewards rate:
Earn 8x points on Chase Travel purchases (replacing the 10x points on hotels and car rentals through Chase Travel and 5x points on flights through Chase Travel)
Earn 4x points when you book directly with an airline or hotel (replacing the 3x points on travel purchases category)
$300 dining credit: Receive up to $300 annual credit (up to $150 from January through June and up to $150 from July through December) when dining with Sapphire Reserve Exclusive Tables.
$500 The Edit credit: Receive up to $500 annual credit for prepaid bookings made with The Edit, a hand-picked collection of hotels and resorts
$300 StubHub credit: Get up to $300 in annual statement credits (up to $150 from January through June and another $150 from July through December) on concert and event tickets purchased on StubHub and viagogo. Activation is required for this credit.
Peloton benefits: Earn 10x points on eligible Peloton purchases (up to 50,000 total points) and get up to $120 in annual statement credits (up to $10 per month) toward eligible Peloton memberships.
Complimentary Apple TV+ and Apple Music: Through June 22, 2027, you can receive complimentary subscriptions to Apple TV+ and Apple Music.
Points Boost: Receive up to 2x redemption value on select hotels and flights booked through Chase Travel
Reserve Travel Designers: Build and book custom trip itineraries with a Reserve Travel Designer.
IHG One Rewards Platinum Elite status: Receive complimentary IHG Platinum Elite status until December 21, 2027.
Spend $75,000 in a calendar year to unlock additional benefits for the remainder of the year and through the following calendar year:
IHG One Rewards Diamond Elite status
$500 Southwest Airlines credit
A-List status with Southwest Airlines
Up to $250 in statement credits on purchases made through The Shops at Chase
These are some of the benefits and features of the Sapphire Reserve for Business:
$795 annual fee
8x points on Chase Travel purchases
4x points on flights and hotels booked direct
3x points on advertising purchases made with social media sites and search engines
$300 annual travel credit - the most flexible travel credit available
$120 Global Entry, TSA Precheck, or Nexus credit every four years
$500 annual The Edit credit
Points Boost
Complimentary IHG One Rewards Platinum Elite Status
Access to the Chase Sapphire Lounge by The Club and Priority Pass Select airport lounge networks
$400 ZipRecruiter credit
$200 Google Workspace credit
$100 Giftcards.com credit
$300 annually in monthly DoorDash promos and complimentary DashPass membership
$120 in annual Lyft in-app credits (up to $10 monthly) plus 5x total points on eligible Lyft rides
Spend $120,000 in a calendar year to receive these benefits:
IHG One Rewards Diamond Elite Status
Southwest Airlines A-List Status and a $500 Southwest Airlines credit when booked through Chase Travel
$500 credit to The Shops at Chase
Editorial Disclosure: The information in this article has not been reviewed or approved by any advertiser. All opinions belong solely to the Yahoo Finance and are not those of any other entity. The details on financial products, including card rates and fees, are accurate as of the publish date. All products or services are presented without warranty. Check the bank's website for the most current information. This site doesn't include all currently available offers. Credit score alone does not guarantee or imply approval for any financial product.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
44 minutes ago
- Business Wire
Lincoln Financial Enhances Fixed Indexed Annuities With New Cap Lock Strategy and Exclusive Nasdaq Priva™ Index
RADNOR, Pa.--(BUSINESS WIRE)-- Lincoln Financial (NYSE: LNC) announced today the latest enhancements to its fixed indexed annuities (FIAs) to help meet investor needs for more upside growth opportunity and diversification. Lincoln has added a 1 Year Cap Lock account that tracks the performance of the S&P 500® and a 1 Year Participation account that tracks the performance of the Nasdaq Priva™ Index, available exclusively with a Lincoln OptiBlend ® fixed indexed annuity. 'In today's market environment, investors want more options for predictable growth and protection from volatility to help them feel confident in their financial plan. FIAs inherently offer full protection when markets are down, and Lincoln's new Cap Lock strategy adds certainty by locking-in their cap for the duration of the term for when markets are up, giving investors greater assurance in their investment outcome,' said Dan Herr, SVP, annuity product management at Lincoln Financial. 'With our latest FIA innovations, Lincoln continues to focus on meeting the needs of consumers as we accelerate our strategic focus on growing spread-based businesses.' New features include: The 1 Year S&P 500 Cap Lock account offers investors growth up to the cap, which is 'locked in' for multiple years, when index performance is positive, and 100% downside protection when the index performance is negative. Locking in the cap rate helps investors balance stability and growth opportunities. The 1 Year Nasdaq Priva™ Participation account allows investors to participate in the upside potential of innovation-driven and new economy equity growth with downside protection. The Nasdaq Priva™ Index is a core equity-only strategy that aims to provide access to innovative, growth-oriented equities, and is designed to adapt to changing regimes in inflation and interest rates. 'The Nasdaq Priva™ Participation account provides investors with opportunities for greater upside growth in positive markets and diversification with highly experienced asset management — exclusively through a Lincoln FIA,' said Tim Seifert, SVP, head of retirement solutions distribution at Lincoln Financial. 'With Lincoln's new FIA strategies, financial professionals can provide clients with more choices for growth without sacrificing protection.' To learn more about the competitive features and benefits of Lincoln FIAs, visit: To learn more about our latest enhancements, view the resources below: Cap Lock account flyer Nasdaq Priva™ Index flyer Editor's note: Lincoln executives celebrated the launch of the Nasdaq Priva™ Index at the Nasdaq Tower in Times Square today. High-resolution photos are available upon request. Lincoln OptiBlend ® fixed indexed annuities (contract form ICC1515-619 and state variations) are issued by The Lincoln National Life Insurance Company, Fort Wayne, IN, and distributed by Lincoln Financial Distributors, Inc., a broker-dealer. The Lincoln National Life Insurance Company does not solicit business in the state of New York, nor is it authorized to do so. Contractual obligations are subject to the claims-paying ability of The Lincoln National Life Insurance Company. About Lincoln Financial Lincoln Financial helps people confidently plan for their vision of a successful financial future. As of December 31, 2024, approximately 17 million customers trust our guidance and solutions across four core businesses – annuities, life insurance, group protection, and retirement plan services. As of June 30, 2025, the company had $331 billion in end-of-period account balances, net of reinsurance. Headquartered in Radnor, PA., Lincoln Financial is the marketing name for Lincoln National Corporation (NYSE: LNC) and its affiliates. Learn more at **Photo assets available LCN-8188956-071825
Business Wire
44 minutes ago
- Business Wire
NEO Home Loans Division Leader, Josh Mettle, Helps 82 Families in One Month Citing Technology Efficiencies and Team Synergy
SALT LAKE CITY--(BUSINESS WIRE)--NEO Home Loans powered by Better, a retail mortgage lender pairing elite loan advisors with agentic mortgage technology to redefine the home financing experience, proudly announces a standout performance from Division Leader Josh Mettle and his team, who helped 82 families achieve homeownership in July. This milestone marks the group's highest monthly total in over three years, reflecting the successful convergence of cutting-edge technology, operational precision, and a high-performance team culture. 'At this point, we're seeing the full impact of systems that have been years in the making,' said Josh Mettle, Division President at NEO Home Loans. 'The efficiencies we've gained from Tinman® AI Platform and Betsy™ AI assistant allowed our team to operate with greater precision and less chaos. Over 90% of our loans were clear-to-close 10 days ahead of the close of the month in July; something almost unheard of in this industry.' Tinman® AI Platform, the proprietary loan origination platform built by Better, enabled fast, seamless file movement from application to close, while Betsy™, the first voice-based AI loan assistant built exclusively for the mortgage system, ensured successful automated loan milestone management. Together, these tools empowered Mettle's team to deliver an elevated client experience at scale. 'These tools didn't just help us do more, they helped us do better,' Mettle added. 'With operational friction removed, our team had the time and clarity to show up at a higher level for every client.' Beyond the technology, Mettle emphasized that the collaborative spirit and mission-driven culture of NEO Home Loans powered by Better have become a magnet for top real estate agents and business partners. 'People want to work with NEO because we bring something different to the table,' he said. 'Our advisors are equipped with tools and strategies that drive long-term financial success, not just transactional outcomes. That kind of value resonates with loan officers who want to build trust and grow with intention.' Ryan Grant, President and Co-Founder of NEO Home Loans powered by Better, applauded the team's achievement: 'Josh's success this month is more than a headline; it's a reflection of what's possible when great leadership meets great infrastructure. Our mission has always been to build a company where advisors can scale, serve, and lead with purpose. This is what that looks like in action.' With another record month projected for August, Mettle's team is showing that modern mortgage success isn't built on volume alone. NEO Home Loans powered by Better is proving success is built on vision, execution, and deep-rooted partnerships. For top-producing loan officers seeking more than just a new company, NEO Home Loans powered by Better offers a future-ready platform built to scale your impact, streamline your operations, and align your business with purpose-driven growth. Find out more at About NEO Home Loans powered by Better NEO Home Loans powered by Better is a tech-forward mortgage company committed to reshaping the lending experience through education, transparency, and personalized strategy. NEO blends cutting-edge technology with expert human guidance to help clients make smarter financial decisions. With a national footprint and a local advisor model, NEO empowers mortgage professionals to scale their businesses with greater autonomy, efficiency, and impact. NEO powered by Better is setting a new standard in lending. Learn more at About Better Home & Finance Holding Company (NASDAQ: BETR; BETRW) is the first AI-powered mortgage lender and first fintech to fund more than $100 billion in mortgage volume. Since 2016, Better has leveraged its industry-leading AI platform, Tinman™, to achieve a singular mission of making homeownership cheaper, faster, and easier for Americans. Tinman™ allows customers to see their rate options in seconds, get pre-approved in minutes, lock in rates, and close their loan in as little as three weeks. In addition, Betsy™, the first voice-based AI loan assistant built exclusively for the mortgage industry, revolutionizes the homebuying journey by delivering timely application status updates to consumers, answering questions, and moving their loan application along 24/7/365. Better's mortgage offerings include GSE-conforming mortgage loans, FHA and VA loans, and jumbo mortgage loans. In January 2023, Better launched "One Day Mortgage,' allowing eligible customers to go from click to Commitment Letter within 24 hours. Better won the 2025 Fintech Breakthrough Awards for Digital Mortgage Innovation, and was named Best Online Mortgage Lender by Forbes and Best Mortgage Lender for Affordability by WSJ in 2023, ranked #1 on LinkedIn's Top Startups List for 2021 and 2020, #1 on Fortune's Best Small and Medium Workplaces in New York, #15 on CNBC's Disruptor 50 2020 list, and was listed on Forbes FinTech 50 for 2020. Better serves customers in all 50 US states and the United Kingdom. For more information, follow @betterdotcom on Instagram and TikTok.
Business Wire
44 minutes ago
- Business Wire
GoodRx Announces Collaboration with Novo Nordisk to Expand Access to Ozempic
BUSINESS WIRE)-- GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced that via a collaboration with Novo Nordisk, all strengths of Ozempic ® (semaglutide) and Wegovy ® (semaglutide) pens are available to eligible self-paying patients for $499-per-month through GoodRx, effective today. This collaboration significantly lowers the price available on GoodRx for two of the most in-demand GLP-1 medications nationwide, expanding access for those who lack adequate insurance coverage. Today also marks the first time Ozempic ® has been made available to patients at this self-pay price. 'Demand for GLP-1 medications is at an all-time high, but too many Americans still face barriers accessing them,' said Wendy Barnes, President and Chief Executive Officer of GoodRx. 'By partnering with Novo Nordisk, we're taking a significant step forward in making these innovative brand-name treatments more accessible for millions of people who need them. It's a powerful example of how the GoodRx platform can deliver savings at scale—bridging gaps in coverage and ensuring more people can get the care they deserve.' In the last year, almost 17 million people came to GoodRx looking for savings and information on GLP-1 medications, a 22% increase from the previous year. Now, GoodRx is poised to more effectively meet this growing demand by leveraging the extensive reach and scale of its trusted platform to deliver savings directly to patients who need them. This collaboration represents a significant milestone in improving access and affordability of these important, authentic, FDA-approved medications. 'Improving access to effective FDA-approved treatment is central to our mission, and our collaboration with GoodRx allows us to reach those who seek savings and support from their trusted and established platform,' said Dave Moore, Executive Vice President, US Operations of Novo Nordisk Inc. 'This initiative enables us to meet GoodRx patients where they are with our authentic GLP-1 medicines in addition to supporting the launch of the new Ozempic ® self-pay offer for type 2 diabetes patients at an unprecedented price.' Healthcare professionals are increasingly prescribing these groundbreaking medications to support patients diagnosed with type 2 diabetes or obesity—yet insurance coverage remains a challenge for many seeking treatment, especially those seeking obesity medications. For example, GoodRx research shows 19 million people lack coverage for any GLP-1s prescribed for weight loss. By filling the gaps in insurance coverage, GoodRx is playing a critical role in reducing friction in the system and helping accelerate speed to therapy so consumers can benefit from these critical treatments. Starting today, eligible patients can use GoodRx to self-pay for Ozempic ® and Wegovy ® pens for $499-per-month at over 70,000 retail pharmacies nationwide. To learn more, visit: or About GoodRx GoodRx is the leading platform for medication savings in the U.S., used by nearly 30 million consumers and over one million healthcare professionals annually. Uniquely situated at the center of the healthcare ecosystem, GoodRx connects consumers, healthcare professionals, payers, PBMs, pharma manufacturers, and retail pharmacies to make saving on medications easier. By reducing friction and inefficiencies, GoodRx helps consumers save time and money when filling prescriptions so they can get the care they deserve. Since 2011, GoodRx has helped Americans save over $85 billion on the cost of their medications. GoodRx periodically posts information that may be important to investors on its investor relations website at We intend to use our website as a means of disclosing material nonpublic information and for complying with our disclosure obligations under Regulation FD. Accordingly, investors and potential investors are encouraged to consult GoodRx's website regularly for important information, in addition to following GoodRx's press releases, filings with the Securities and Exchange Commission (the 'SEC') and public conference calls and webcasts. The information contained on, or that may be accessed through, GoodRx's website is not incorporated by reference into, and is not a part of, this press release. GoodRx Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements regarding anticipated consumer savings, convenience and accessibility; the expected benefits and value of our offerings to consumers, GoodRx, Novo Nordisk and other pharmaceutical manufacturers. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, risks relating to our ability to achieve broad market education and change consumer purchasing habits; changes in medication pricing and pricing structures; our reliance on a limited number of industry participants; and the important factors discussed under the caption 'Risk Factors' in our Annual Report on Form 10-K for the year ended December 31, 2024, and our other filings with the SEC. Any such forward-looking statements are based on current expectations, projections and estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change.
